Group Leader
Jaume Alijotas Reig
Principal Investigator (PI)
Francesc Miró Mur, Albert Selva O’Callaghan, Carmen Pilar Simeón Aznar, Roser Solans Laqué, Josep Pardos Gea, Moisés Labrador Horrillo, Segundo Buján Rivas, Mar Guilarte Clavero, Victòria Cardona Dahl
Researchers
Anna Sala Cunill, Alfredo Guillén del Castillo, Olga Luengo Sánchez, Fernando Martínez Valle, Jaume Mestre Torres, Enrique Esteve Valverde
PhD Students
Ariadna Anunciación Llunell, Joana Marques Soares
Lab Technicians
Laura Donaire, Daniel Granados Pino
64
PUBLICATIONS
51.6%
%Q1
679
IMPACT FACTOR
10.61
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Pardos-Gea J, Marques-Soares JR, Bujan S, Ordi-Ros J, Alijotas-Reig J
Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study
Rheumatology (Oxford). 2022 Mar 2;61(3):1053-1061
DOI: doi: 10.1093/rheumatology/keab475
IF: 7.046
Mestre-Torres J, Martinez-Valle F, Gabaldon A, Simo-Perdigo M, Salcedo-Allende MT, Navales-Mateu I, Solans-Laque R
Are Temporal Artery Biopsy Findings Related to PET/CT Findings in Giant Cell Arteritis?
Clin Nucl Med. 2022 May 1;47(5):387-393
DOI: doi: 10.1097/RLU.0000000000004097
IF: 10.782
Carbonell C, Marcos M, Guillen-Del-Castillo, Rubio-Rivas M, Argibay A, Marin-Ballve A, Rodriguez-Pinto I, Balda-Masmiquel M, Callejas-Moraga E, Colunga D, Saez-Comet L, Gonzalez-Echavarri C, Ortego-Centeno N, Mari-Alfonso B, Vargas-Hitos JA, Todoli-Parra JA, Trapiella L, Herranz-Marin MT, Freire M, Castro-Salomo A, Perales-Fraile I, Madronero-Vuelta AB, Sanchez-Garcia ME, Ruiz-Munoz M, Gonzalez-Garcia A, Sanchez-Redondo J, de-la-Red-Bellvis G, Fernandez-Luque A, Muela-Molinero A, Lledo GM, Tolosa-Vilella C, Fonollosa-Pla V, Chamorro AJ, Simeon-Aznar CP
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)
Autoimmun Rev. 2022 Oct;21(10):103167
DOI: doi: 10.1016/j.autrev.2022.103167
IF: 17.39
Gimenez-Arnau A, Bartra J, Ferrer M, Jauregui I, Borbujo J, Figueras I, Munoz-Bellido FJ, Pedraz J, Serra-Baldrich E, Tejedor-Alonso MA, Velasco M, Terradas P, Labrador MA
Specialized Therapeutic Approach to Chronic Urticaria Patient’s Refractory to H1-Antihistamines Improves the Burden of the Disease. The Spanish AWARE Experience
J Investig Allergol Clin Immunol. 2022 Jun 20;32(3):191-199
DOI: doi: 10.18176/jiaci.0661
IF: 8.185
Anunciacion-Llunell , Munoz C, Roggenbuck D, Frasca S, Pardos-Gea J, Esteve-Valverde E, Alijotas-Reig J, Miro-Mur F
Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
Int J Mol Sci. 2022 Oct 24;23(21). pii: ijms232112819
DOI: doi: 10.3390/ijms232112819
IF: 6.208
Design of an integrative patient stratification approach for the systemic sclerosis management
Principal Investigator: Carmen Pilar Simeón Aznar
Agency: Fundació La Marató de TV3
Funding: 72,250 €
Period: 2021-ongoing
Infiltrado Tumoral Linfocitario (TILs) y dermatomiositis asociada a cáncer
Principal Investigator: Albert Selva O’Callaghan
Agency: Instituto de Salud Carlos III
Funding: 133,000 €
Period: 2019-2022
Tratorns autoimmunes i al·loimmunes i la seva relació amb trastorns reproductius
Principal Investigator: Jaume Alijotas-Reig
Agency: Fundació Ona Futura / Gravida
Funding: 135,000 €
Period: 2019 –ongoing
Combination of immunosuppressors or immunomodulatory drugs in patients with severe acute infection caused by SARS-CoV-2: cellular and immunological basis
Principal Investigator: Jaume Alijotas-Reig
Agency: Ayudas a la investigación médica SEMCC 2020
Funding: 40,000 €
Period: 2020-2022
Identificación de biomarcadores celulares y moleculares en angioedema idiopático y hereditario para su diferenciación en fenotipos y endotipos
Principal Investigator: Mar Guilarte Clavero
Agency: Instituto de Salud Carlos III
Funding: 84,700 €
Period: 2021 - ongoing